APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval~70% reduction in Gd-IgA1 at 12 weeks ~33-day ...

Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept – - Data published in NEJM and presented at ASN ...

Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic ...

Tempus AI delivers robust 22% YoY revenue growth, forecasting $1.6bn in 2026 and demonstrating strong commercial traction.

Chris Zeng, Overseas Business Manager at Superteam Wheels, commented: "The MATIC S68 is the result of extensive development, ...

The lead antibody is in Phase 2 studies for asthma, COPD and atopic dermatitis; a fourth study is planned, with data from all ...

VIVESCIA cooperative group and its malting business have announced the acquisition of the Chunlei Malting Co. plant. With ...

Climb Bio, Inc. (Nasdaq: CLYM, “Climb Bio”) and Beijing Mabworks Biotech Co., Ltd. (“Mabworks”), today announced additional Phase 1 data in healthy volunteers for CLYM116/MIL116, an anti-APRIL ...

Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breas ...

Daridorexant, a dual orexin receptor antagonist, is the first investigational treatment in its class to demonstrate positive results in pediatric insomnia disorder, an area in which significant unmet ...

Class A shares of the Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index during the third quarter of 2026.

Govt Job Portal to get info about latest Govt Jobs in India.10th, 12th pass Govt jobs.Best courses after 12th class. Defense ...